Pharmaceutical company Dr Reddy's, which is developing a Covid-19 vaccine, says it has been hit by a cyber-attack. Sites around the world have been affected, including those in the UK, Brazil ...

The U.S. unit of Indian drugmaker Dr. Reddy’s Laboratories is recalling 331,590 bottles of cinacalcet tablets used to treat hyperparathyroidism due to the presence of a known carcinogen. | The U.S.

Dr Reddy’s Laboratories (RDY) has released an update. Dr. Reddy’s Laboratories reported a robust second quarter for FY25, showcasing a 17% year-over-year revenue growth, achieving their highest ever ...

Dr Reddy's Laboratories is aiming to move up to the fifth rank in the Indian pharma market within the next five years, the company's chief financial officer, M.V. Narasimham, said in an exclusive ...

Dr. Reddy’s Laboratories Ltd ( (RDY) ) has released its Q2 earnings. Here is a breakdown of the information Dr. Reddy’s ...

Dr Reddy's was also hit by one-time charges related to its joint venture with Nestle India and Nicotinell acquisition. Also Read: Dr Reddy’s recalls over 3 lakh bottles of Cinacalcet tablets in ...

Dr. Reddy’s Laboratories announced a 1:5 stock split on Saturday, meaning each share with a face value of Rs 5 will be divided into five shares with a face value of Re 1. The record date for the ...

Much like the trend in the domestic pharma industry, Dr Reddy's Laboratories is investing heavily in research and development aimed at ramping up the biosimilars, generics, and biologics segments.